Base Year
Historical Year
Forecast Year
The sarcopenia market size is expected to grow at a CAGR of 4.3% during the forecast period of 2024-2032. The market is driven by the growing geriatric population and the increased research activities to mitigate the impact of sarcopenia on aging patients across the 8 major markets.
Sarcopenia is characterized by a progressive decline in muscle strength and mass. Muscle weakness is a common symptom of this age-related condition. A sedentary lifestyle and unhealthy eating habits can put an individual at a higher risk of the disease. The prevalence of sarcopenia is estimated to be 10-16% among the geriatric population. The condition was reported to affect 18% of diabetic patients and 66% of patients with unresectable esophageal cancer. The increasing geriatric population base, prone to developed this skeletal muscle disorder is expected to fuel the demand for effective treatment driving sarcopenia market growth in the forecast period.
In July 2023 , a biotechnology company headquartered in France, Biophytis BSA, filed for the United States Food and Drug Administration (FDA) approval for SARA-31, the first Phase III study targeting sarcopenia. SARA-31 will evaluate Sarconeos' (BIO101) effectiveness and safety in treating sarcopenic patients prone to mobility issues. Sarconeos (an orally administered small molecule) has shown promise in Phase IIb trials. The Phase III study aims to enrol around 900 patients aged over 65 with severe sarcopenia, low walking speed, and grip strength. The development of such innovative treatment approaches to address the growing cases of sarcopenia is projected to propel the sarcopenia market demand.
The market is witnessing steady growth which can be attributed to factors such as the growing investment in research and development projects and increasing demand for pharmacological interventions aimed at enhancing muscle mass and function.
| Key Trends | Description |
| Increased Recognition and Diagnosis | Sarcopenia is increasingly recognized as a distinct condition. This has led to improved diagnostic criteria and screening tools to identify and manage it early. |
| Nutritional Interventions | There is an increased focus on nutritional strategies, particularly protein supplementation and vitamin D, to treat or manage sarcopenia. Such interventions reflect the critical role of diet in muscle health. |
| Physical Activity and Exercise Programs using Wearable Technologies | The development of wearable technology and mobile applications to monitor the physical activity of sarcopenia patients can help improve patient outcomes. |
| Pharmacological Developments | Ongoing research into pharmacological treatments, such as anabolic agents and selective androgen receptor modulators (SARMs), aimed at directly enhancing muscle mass and function, are expected to influence the market landscape. |
Market Breakup by Treatment Type
The market segmentation by treatment type includes protein supplements, vitamin B12 supplements, vitamin D & calcium supplements, pharmacotherapy, and others. Protein supplements help promote muscle protein synthesis and counteract muscle loss in sarcopenia patients. Vitamin B12 supplements help address deficiencies often observed in older adults. Vitamin D & calcium supplements address potential deficiencies associated with sarcopenia by supporting bone health and muscle function. Pharmacotherapy involves medications targeting muscle mass and function to treat sarcopenia.
Market Breakup by Route of Administration
Based on the route of administration, the sarcopenia market share includes oral, parenteral, and others. In oral administration, medications are taken via mouth. On the other hand, parenteral administration involves injections or infusions.
Market Breakup by End User
Major end users of the market include hospitals, homecare, specialty clinics, and others. They offer specialized expertise and care for sarcopenia patients.
Market Breakup by Distribution Channel
The distribution channels in the sarcopenia market constitute hospital pharmacies, retail pharmacies, online pharmacies, and others. To ensure accessibility and availability of sarcopenia treatments, this segment offers various channels to cater to the diverse needs of the patients.
Market Breakup by Region
Based on the region, the market includes the United States, EU-4 (Germany, France, Italy, Spain), United Kingdom, Japan, and China. North America dominates the regional market, attributed to the presence of key market players and a robust healthcare system. Rapid technological advancements and the growth of the elderly population in the region further bolster the market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is anticipated to grow at a CAGR of 4.3% during the forecast period of 2024-2032, driven by the growing geriatric population across the 8 major markets.
Factors such as rising healthcare expenditure, heightened patient awareness along with research activities to mitigate the impact of sarcopenia on aging patients are fuelling the demand for the market.
One of the significant trends in the market is the development of innovative and effective treatment approaches to address the growing cases of sarcopenia. In July 2023, Biophytis BSA filed for the United States Food and Drug Administration (FDA) approval for SARA-31, the first Phase III study targeting sarcopenia. SARA-31 will evaluate its product Sarconeos' (BIO101) effectiveness and safety in treating sarcopenic patients prone to mobility issues.
The market segmentation by treatment type includes protein supplements, vitamin B12 supplements, vitamin D & calcium supplements, pharmacotherapy, and others.
Based on the route of administration, the market includes oral, parenteral, and others.
Major end users of the market include hospitals, homecare, specialty clinics, and others.
The distribution channels in the market include hospital pharmacies, retail pharmacies, online pharmacies, and others.
The major regions of the market include the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and China.
Key players involved in the market are Amgen Inc., F-Hoffmann La-Roche, American Way (Amway) Corporation, Abbott Laboratories, Inc., AbbVie Inc., Merck Sharp & Dohme Corp., AstaReal AB, Pfizer Inc., Sanofi S.A., Nestle Health Science, Zydus Cadila, Bayer AG, Amgen Inc., Johnson & Johnson., and Novartis AG.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share